NO20000822L - Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander - Google Patents

Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander

Info

Publication number
NO20000822L
NO20000822L NO20000822A NO20000822A NO20000822L NO 20000822 L NO20000822 L NO 20000822L NO 20000822 A NO20000822 A NO 20000822A NO 20000822 A NO20000822 A NO 20000822A NO 20000822 L NO20000822 L NO 20000822L
Authority
NO
Norway
Prior art keywords
substituted
agonists
carboxamides
oxo
receptor ligands
Prior art date
Application number
NO20000822A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000822D0 (no
Inventor
Pamela Albaugh
Robert W Desimone
Gang Liu
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of NO20000822D0 publication Critical patent/NO20000822D0/no
Publication of NO20000822L publication Critical patent/NO20000822L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000822A 1997-08-25 2000-02-18 Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander NO20000822L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25
PCT/US1998/017513 WO1999010347A1 (fr) 1997-08-25 1998-08-24 4-oxo-naphtyridine-3-carboxamides substitues comme ligands de recepteur de gaba du cerveau

Publications (2)

Publication Number Publication Date
NO20000822D0 NO20000822D0 (no) 2000-02-18
NO20000822L true NO20000822L (no) 2000-04-13

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000822A NO20000822L (no) 1997-08-25 2000-02-18 Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander

Country Status (24)

Country Link
EP (1) EP1007526A1 (fr)
JP (1) JP2001514181A (fr)
KR (1) KR20010023313A (fr)
CN (1) CN1268136A (fr)
AP (1) AP2000001742A0 (fr)
AU (1) AU753800B2 (fr)
BG (1) BG104192A (fr)
BR (1) BR9811362A (fr)
CA (1) CA2301599C (fr)
EG (1) EG21717A (fr)
HU (1) HUP0003258A3 (fr)
IL (1) IL134291A0 (fr)
IS (1) IS5382A (fr)
LV (1) LV12539B (fr)
NO (1) NO20000822L (fr)
NZ (1) NZ502548A (fr)
OA (1) OA11293A (fr)
PE (1) PE130999A1 (fr)
PL (1) PL338783A1 (fr)
SI (1) SI20270A (fr)
SK (1) SK2162000A3 (fr)
TW (1) TW574221B (fr)
WO (1) WO1999010347A1 (fr)
YU (1) YU10500A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4818000A (en) * 1999-05-06 2000-11-21 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
AU5289600A (en) 1999-05-25 2000-12-12 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
SK4322003A3 (en) 2000-10-12 2003-09-11 Merck & Co Inc Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
ATE345129T1 (de) 2000-10-12 2006-12-15 Merck & Co Inc Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
EE200300422A (et) * 2001-03-01 2004-02-16 Pfizer Products Inc. GABAA pöördagonistide kasutamine kombinatsioonis nikotiiniretseptori osaliste agonistide, östrogeeni, selektiivsete östrogeeni modulaatorite või vitamiin E-ga kognitiivsete häirete raviks
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
US7279487B2 (en) 2002-01-17 2007-10-09 Merck & Co., Inc. Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
JP4494020B2 (ja) 2002-03-15 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド
WO2004106336A1 (fr) * 2003-05-27 2004-12-09 Pfizer Products Inc. Procede de preparation et de purification de 1,5-naphtyridine-3-carboxyamides
WO2004106334A2 (fr) * 2003-05-28 2004-12-09 Pfizer Products Inc. Procede de preparation de 1,5-naphtyridine-3-carboxyamides par amidation directe d'esters
US8293737B2 (en) * 2006-10-16 2012-10-23 Bionomics Limited Anxiolytic compounds
JP2010510314A (ja) * 2006-11-22 2010-04-02 シーサイド セラピューティクス，エルエルシー 精神遅滞、ダウン症候群、脆弱ｘ症候群および自閉症の治療方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204162A1 (es) * 1972-05-08 1975-11-28 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampicilina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
SK2162000A3 (en) 2001-03-12
WO1999010347A1 (fr) 1999-03-04
YU10500A (sh) 2002-10-18
OA11293A (en) 2002-11-19
LV12539A (en) 2000-10-20
NO20000822D0 (no) 2000-02-18
BR9811362A (pt) 2000-08-22
HUP0003258A2 (en) 2001-03-28
PL338783A1 (en) 2000-11-20
LV12539B (en) 2001-01-20
AU753800B2 (en) 2002-10-31
EP1007526A1 (fr) 2000-06-14
EG21717A (en) 2002-02-27
PE130999A1 (es) 1999-12-16
IL134291A0 (en) 2001-04-30
CN1268136A (zh) 2000-09-27
HUP0003258A3 (en) 2001-05-28
JP2001514181A (ja) 2001-09-11
IS5382A (is) 2000-02-22
AP2000001742A0 (en) 2000-02-24
TW574221B (en) 2004-02-01
BG104192A (en) 2001-05-31
CA2301599A1 (fr) 1999-03-04
SI20270A (sl) 2000-12-31
CA2301599C (fr) 2003-03-25
NZ502548A (en) 2002-06-28
KR20010023313A (ko) 2001-03-26
AU9117398A (en) 1999-03-16

Similar Documents

Publication Publication Date Title
NO20000822L (no) Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander
CA2175204A1 (fr) Pyrrolecarboxanilides fusionnes constituant une nouvelle classe de ligands des recepteurs gaba du cerveau
DE60018274D1 (de) Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
CA2243317A1 (fr) Nouvelles pyrrolecarboxamides fusionnees; une nouvelle classe de ligands de recepteurs gaba dans le cerveau
HUP0000079A2 (hu) Indán- és dihidroindolszármazékok
DE69636670D1 (de) Benzimidazolverbindungen und ihre verwendung als gaba a receptor komplex modulatoren
DK0555391T3 (da) Visse imidazoquinoxaliner; en ny klasse GABA-receptorligander i hjernen
WO1999043660A1 (fr) Carboxamides 1,4-dihydro-4-oxonicotiniques substitues; ligands des recepteurs gaba du cerveau
WO1999043661A3 (fr) Carboxamides cycloalkyl-4-oxonicotiniques substitues; ligands des recepteurs gaba du cerveau
HUP0303630A2 (hu) Imidazo-pirimidin-származékok, mint GABA receptorok ligandumai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69609413T2 (de) BENZIMIDAZOLVERBINDUNGEN UND IHRE VERWENDUNG ALS MODULATOREN DES GABAa-REZEPTORKOMPLEXES
AU2321597A (en) Novel imidazo{1,5-c}quinazolines; a new class of gaba brain receptor ligands
EP4025211A1 (fr) Procédés de traitement de l'épilepsie à l'aide de ceux-ci
BR0009539A (pt) composto, composição farmacêutica, método para tratamento ou prevenção de uma doença ou distúrbio associado com agonismo patogênico, agonismo inverso ou antagonismo do receptor gaba a, uso de um composto, método para localizar receptores gaba a em uma amostra de tecido, método para alterar a atividade transdutora de sinal de receptores gaba a, método para o tratamento ou prevenção de distúrbios psicológicos associados com modulação do complexo receptor gaba a, e, processo para a preparação de um composto
ATE482931T1 (de) Somatostatinrezeptor-1- und/oder -4-selektive agonisten und antagonisten
DE69926378D1 (de) Oxo-pyridoimidazol-carboxamide: gaba-rezeptor-liganden im gehirn
CA2249562A1 (fr) Certains pyrrolecarboxamides fusionnes utilises comme ligands de recepteurs cerebraux gaba
BR112019028078A2 (pt) derivados de 2-oxo-1,3-oxazolidinil imidazotiadiazol
AR007742A1 (es) Pirrolcarboxanilidas fusionadas; una nueva clase de ligandos receptores gaba del cerebro.
TH35993A (th) ฟิวส์ พิร์โรลคาร์บอกแซนิไลด์
BR9807840A (pt) Derivados de 4-aminoalcóxi-1,3-dihidrobenzoimidazol-2-tionas, sua preparação e seu uso como agonistas de auto-receptor de dopamina (d2)
MXPA01006351A (en) Diphenylurea compounds
TH52364A (th) ปรปักษ์ของตัวรับเบนซอกซาซิโนนโดพามีน d4

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application